Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands

Congenital heart disease (CHD) is the leading cause of mortality from birth defects. Here, exome sequencing of a single cohort of 2,871 CHD probands, including 2,645 parent–offspring trios, implicated rare inherited mutations in 1.8%, including a recessive founder mutation in GDF1 accounting for ∼5% of severe CHD in Ashkenazim, recessive genotypes in MYH6 accounting for ∼11% of Shone complex, and dominant FLT4 mutations accounting for 2.3% of Tetralogy of Fallot. De novo mutations (DNMs) accounted for 8% of cases, including ∼3% of isolated CHD patients and ∼28% with both neurodevelopmental and extra-cardiac congenital anomalies. Seven genes surpassed thresholds for genome-wide significance, and 12 genes not previously implicated in CHD had >70% probability of being disease related. DNMs in ∼440 genes were inferred to contribute to CHD. Striking overlap between genes with damaging DNMs in probands with CHD and autism was also found.

[1]  W. Chung,et al.  The Congenital Heart Disease Genetic Network Study Rationale, Design, and Early Results , 2013 .

[2]  Kristiina Aittomäki,et al.  Recessively inherited right atrial isomerism caused by mutations in growth/differentiation factor 1 (GDF1). , 2010, Human molecular genetics.

[3]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[4]  Georgina Peacock,et al.  Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation , 2012 .

[5]  K. Alitalo,et al.  Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[7]  J. Priest,et al.  Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease , 2016, Circulation.

[8]  Mark Yandell,et al.  VAAST 2.0: Improved Variant Classification and Disease-Gene Identification Using a Conservation-Controlled Amino Acid Substitution Matrix , 2013, Genetic epidemiology.

[9]  M. Morishima,et al.  Influence of genetic and maternal diabetes in the pathogenesis of visceroatrial heterotaxy in mice. , 1996, Teratology.

[10]  Alexander R. Pico,et al.  Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage , 2012, Cell.

[11]  Se-Jin Lee,et al.  Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. G. Reese,et al.  A probabilistic disease-gene finder for personal genomes. , 2011, Genome research.

[13]  Y. Saijoh,et al.  Long-range action of Nodal requires interaction with GDF1. , 2007, Genes & development.

[14]  Marc Gewillig,et al.  Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. , 2012, American journal of human genetics.

[15]  Yufeng Shen,et al.  Increased Frequency of De Novo Copy Number Variants in Congenital Heart Disease by Integrative Analysis of Single Nucleotide Polymorphism Array and Exome Sequence Data , 2014, Circulation research.

[16]  A. Shapiro,et al.  Congenital Heart Disease and Primary Ciliary Dyskinesia. , 2016, Paediatric respiratory reviews.

[17]  W. Pu,et al.  Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders. , 2014, Cold Spring Harbor perspectives in medicine.

[18]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[19]  E. Boerwinkle,et al.  dbNSFP v2.0: A Database of Human Non‐synonymous SNVs and Their Functional Predictions and Annotations , 2013, Human mutation.

[20]  H. Boyd,et al.  Recurrence of Congenital Heart Defects in Families , 2009, Circulation.

[21]  Margaret Y. Nettleton,et al.  High throughput in vivo functional validation of candidate congenital heart disease genes in Drosophila , 2017, eLife.

[22]  S. B. Wechsler,et al.  Factors associated with neurodevelopment for children with single ventricle lesions. , 2014, The Journal of pediatrics.

[23]  M. Daly,et al.  Interpreting de novo Variation in Human Disease Using denovolyzeR , 2015, Current protocols in human genetics.

[24]  Brett J. Kennedy,et al.  Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families. , 2014, American journal of human genetics.

[25]  Sean Thomas,et al.  A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac Development , 2012, Cell.

[26]  Arnold Munnich,et al.  Mutation in myosin heavy chain 6 causes atrial septal defect , 2005, Nature Genetics.

[27]  Bruce Rannala,et al.  DMLE+: Bayesian linkage disequilibrium gene mapping , 2002, Bioinform..

[28]  Tomas W. Fitzgerald,et al.  Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing , 2016, Nature Genetics.

[29]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[30]  S. Colan,et al.  Comparison of shunt types in the Norwood procedure for single-ventricle lesions. , 2010, The New England journal of medicine.

[31]  J. Stockman,et al.  Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions , 2012 .

[32]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[33]  Murim Choi,et al.  De novo mutations in histone modifying genes in congenital heart disease , 2013, Nature.

[34]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[35]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[36]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[37]  A. Egbe,et al.  Prevalence of congenital anomalies in newborns with congenital heart disease diagnosis , 2014, Annals of pediatric cardiology.

[38]  J. Reefhuis,et al.  Long-term outcomes in children with congenital heart disease: National Health Interview Survey. , 2015, The Journal of pediatrics.

[39]  Kali T. Witherspoon,et al.  Excess of rare, inherited truncating mutations in autism , 2015, Nature Genetics.

[40]  Robert E. Ferrell,et al.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema , 2000, Nature Genetics.

[41]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[42]  Wei Chen,et al.  Sequence analysis A Bayesian framework for de novo mutation calling in parents-offspring trios , 2015 .

[43]  N. Norton,et al.  Coding Sequence Rare Variants Identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 From 312 Patients With Familial or Idiopathic Dilated Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.

[44]  C. Rankin,et al.  Regulation of left-right patterning in mice by growth/differentiation factor-1 , 2000, Nature Genetics.

[45]  B. Keavney,et al.  Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation , 2012, Human mutation.

[46]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[47]  J. K. Fraley,et al.  Mitral valve morphology and morbidity/mortality in Shone's complex. , 2005, The American journal of cardiology.

[48]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[49]  J. Seidman,et al.  Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly , 2002, Circulation.

[50]  Chaolong Wang,et al.  Ancestry estimation and control of population stratification for sequence-based association studies , 2014, Nature Genetics.

[51]  M. Brueckner,et al.  Genetics and Genomics of Congenital Heart Disease. , 2017, Circulation research.

[52]  L. Hudgins,et al.  Consanguinity and the risk of congenital heart disease , 2012, American journal of medical genetics. Part A.

[53]  J. Roos‐Hesselink,et al.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. , 2011, Journal of the American College of Cardiology.

[54]  Hongyu Zhao,et al.  Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles , 2016, eLife.

[55]  John Hwa,et al.  Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome , 2013, Nature Genetics.

[56]  S. Warren,et al.  Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population , 2010, Proceedings of the National Academy of Sciences.

[57]  C. I. Spencer,et al.  KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation , 2016, Development.

[58]  Janan T. Eppig,et al.  Global genetic analysis in mice unveils central role for cilia in congenital heart disease , 2015, Nature.

[59]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[60]  R. Gibbs,et al.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.

[61]  Eric D Wieben,et al.  Recessive MYH6 Mutations in Hypoplastic Left Heart With Reduced Ejection Fraction , 2015, Circulation. Cardiovascular genetics.

[62]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.